SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-341744
Filing Date
2017-11-14
Accepted
2017-11-14 07:18:27
Documents
66
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d460971d10q.htm 10-Q 723129
2 EX-2.1 d460971dex21.htm EX-2.1 131269
3 EX-4.1 d460971dex41.htm EX-4.1 127284
4 EX-31.1 d460971dex311.htm EX-31.1 6151
5 EX-31.2 d460971dex312.htm EX-31.2 6074
6 EX-32.1 d460971dex321.htm EX-32.1 3530
7 EX-32.2 d460971dex322.htm EX-32.2 3439
  Complete submission text file 0001193125-17-341744.txt   3650707

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dcph-20170930.xml EX-101.INS 447083
9 XBRL TAXONOMY EXTENSION SCHEMA dcph-20170930.xsd EX-101.SCH 39544
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dcph-20170930_cal.xml EX-101.CAL 46721
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dcph-20170930_def.xml EX-101.DEF 256130
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20170930_lab.xml EX-101.LAB 295122
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20170930_pre.xml EX-101.PRE 307134
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38219 | Film No.: 171198306
SIC: 2834 Pharmaceutical Preparations